MMedication Read More FDA Issues Alert on Compounded Topical Finasteride Risks24 April 2025 The US Food and Drug Administration (FDA) said Tuesday it has become aware of reports of adverse events…
MMedication Read More FDA Authorizes First Digital Therapeutic for Migraine19 April 2025 The US Food and Drug Administration (FDA) has granted marketing authorization to CT-132 (Click Therapeutics), an adjunctive, first-in-class…
MMedication Read More FDA Issues Warning About Counterfeit Ozempic15 April 2025 The U.S. Food and Drug Administration (FDA) and Novo Nordisk are warning people not to use counterfeit semaglutide…
MMedication Read More Alternatives to GLP-1 Medications for Weight Loss – Medscape11 April 2025 Alternatives to GLP-1 Medications for Weight Loss Medscape Weight-loss drugs offer hope, but no magic pill for obesity, say…